Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Shanghai Fosun Pharmaceutical : BioNTech says vaccine pricing benchmark is for similar volumes

11/10/2020 | 11:45am EDT

* Thermal shipping boxes allow for 15-day storage

* CEO says trial to yield data even after switch from placebo

FRANKFURT, Nov 10 (Reuters) - BioNTech on Tuesday signalled that order size would impact the per-dose price for its potential COVID-19 vaccine in the developed world.

"The price for the U.S. for the first 100 million doses was $19.50 per dose," said BioNTech's Chief Strategy Officer Ryan Richardson in an analyst call after the release of third-quarter results on Tuesday.

He was referring to a July deal struck by partner Pfizer with the U.S. government for the supply of the vaccine.

"You can think about that as a benchmark for how we would price the vaccine to the developed world for similar volumes," he added.

The vaccine was on Monday shown to be 90% effective, based on preliminary trial results, a major milestone in the war against a virus that has killed more than a million people and battered the world's economy.

Richardson said at an earlier event on Tuesday that even though the German group had received some public-sector funds, the product price would partly reflect the risks taken by its investors.

The company on Tuesday also said it would use special thermal shipping boxes to transport vials once they are taken out of ultra-low temperature storage.

The vaccine, which belongs to a class known as messenger RNA, will have to be shipped and centrally stored at minus 70 degrees Celsius, Chief Executive Ugur Sahin said on Monday.

The thermal boxes would preserve the ultra-low temperatures for up to 10 days for ambient temperatures of up to 25 degrees Celsius without opening them and up to 15 days if the boxes are opened and then re-iced, BioNTech said in presentation slides.

As previously announced, the vaccine can be kept for up to five days at fridge temperatures.

During the analyst call on Tuesday, Sahin said participants on placebo in a control group could at some point no longer be denied the vaccine when its efficacy is further confirmed.

But for lack of a placebo group, longer-term insight could still be gleaned afterwards by using general infection statistics among the non-vaccinated population as comparison.

"This might give us indirect evidence ... by comparison of epidemiological data, how this long-term protection could evolve," he said.

(Reporting by Ludwig Burger Editing by Edward Taylor and Jane Merriman)


ę Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE -2.92% 305.1 Delayed Quote.284.51%
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 6.25% 74.75 End-of-day quote.38.45%
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
07/28SHANGHAI FOSUN PHARMACEUTICAL : An announcement has just been published by the i..
PU
07/19Sisram Medical Seeks $80 Million in Private Placement; Shares Fall 6%
MT
07/19SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement entering into the placing..
PU
07/19SHANGHAI FOSUN PHARMACEUTICAL (GROUP : Ex-dividend day for final dividend
FA
07/14SINOVAC BIOTECH : Fosun-BioNTech COVID-19 vaccine completes China regulator revi..
RE
07/14MARKET CHATTER : BioNTech's COVID-19 Vaccine Advances to Administration Review i..
MT
07/14SHANGHAI FOSUN PHARMACEUTICAL : Poll results of the resolution proposed at the 2..
PU
07/13Hong Kong says no personal data shared in vaccine deal with Fosun
RE
07/13Sisram Medical Limited completed the acquisition of Shanghai Foshion Medical ..
CI
07/12Politics, health collided in Taiwan's tortured BioNTech vaccine talks
RE
More news
Financials
Sales 2021 40 257 M 6 236 M 6 236 M
Net income 2021 4 253 M 659 M 659 M
Net Debt 2021 15 917 M 2 466 M 2 466 M
P/E ratio 2021 44,1x
Yield 2021 0,70%
Capitalization 181 B 28 044 M 28 047 M
EV / Sales 2021 4,89x
EV / Sales 2022 4,34x
Nbr of Employees 32 258
Free-Float 58,8%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | 600196 | CNE000000X38 | MarketScreener
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 74,75 CNY
Average target price 57,08 CNY
Spread / Average Target -23,6%
EPS Revisions
Managers and Directors
Xiao Hui Guan Executive President & Chief Financial Officer
Yu Qing Chen Co-President
Ke Xin Wang Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman